Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 148

1.

RGDfK-Peptide Modified Alginate Scaffold for Cell Transplantation and Cardiac Neovascularization.

Sondermeijer HP, Witkowski P, Seki T, van der Laarse A, Itescu S, Hardy MA.

Tissue Eng Part A. 2018 May;24(9-10):740-751. doi: 10.1089/ten.TEA.2017.0221. Epub 2017 Nov 13.

PMID:
28938862
2.

Safety, tolerability, clinical, and joint structural outcomes of a single intra-articular injection of allogeneic mesenchymal precursor cells in patients following anterior cruciate ligament reconstruction: a controlled double-blind randomised trial.

Wang Y, Shimmin A, Ghosh P, Marks P, Linklater J, Connell D, Hall S, Skerrett D, Itescu S, Cicuttini FM.

Arthritis Res Ther. 2017 Aug 2;19(1):180. doi: 10.1186/s13075-017-1391-0.

3.

Immunoselected STRO-3+ mesenchymal precursor cells reduce inflammation and improve clinical outcomes in a large animal model of monoarthritis.

Abdalmula A, Dooley LM, Kaufman C, Washington EA, House JV, Blacklaws BA, Ghosh P, Itescu S, Bailey SR, Kimpton WG.

Stem Cell Res Ther. 2017 Feb 7;8(1):22. doi: 10.1186/s13287-016-0460-7.

4.

Optimization of alginate purification using polyvinylidene difluoride membrane filtration: Effects on immunogenicity and biocompatibility of three-dimensional alginate scaffolds.

Sondermeijer HP, Witkowski P, Woodland D, Seki T, Aangenendt FJ, van der Laarse A, Itescu S, Hardy MA.

J Biomater Appl. 2016 Oct;31(4):510-520. Epub 2016 Apr 25.

5.

Reconstitution of degenerated ovine lumbar discs by STRO-3-positive allogeneic mesenchymal precursor cells combined with pentosan polysulfate.

Oehme D, Ghosh P, Goldschlager T, Itescu S, Shimon S, Wu J, McDonald C, Troupis JM, Rosenfeld JV, Jenkin G.

J Neurosurg Spine. 2016 May;24(5):715-26. doi: 10.3171/2015.8.SPINE141097. Epub 2016 Jan 22.

PMID:
26799116
6.

Evaluation of the safety and tolerability of a high-dose intravenous infusion of allogeneic mesenchymal precursor cells.

McDonald CA, Oehme D, Pham Y, Kelly K, Itescu S, Gibbon A, Jenkin G.

Cytotherapy. 2015 Sep;17(9):1178-87. doi: 10.1016/j.jcyt.2015.05.007. Epub 2015 Jul 15.

PMID:
26188968
7.

A Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients With Ischemic or Nonischemic Heart Failure.

Perin EC, Borow KM, Silva GV, DeMaria AN, Marroquin OC, Huang PP, Traverse JH, Krum H, Skerrett D, Zheng Y, Willerson JT, Itescu S, Henry TD.

Circ Res. 2015 Aug 28;117(6):576-84. doi: 10.1161/CIRCRESAHA.115.306332. Epub 2015 Jul 6.

PMID:
26148930
8.

Effect of mesenchymal precursor cells on the systemic inflammatory response and endothelial dysfunction in an ovine model of collagen-induced arthritis.

Dooley LM, Abdalmula A, Washington EA, Kaufman C, Tudor EM, Ghosh P, Itescu S, Kimpton WG, Bailey SR.

PLoS One. 2015 May 7;10(5):e0124144. doi: 10.1371/journal.pone.0124144. eCollection 2015.

9.

Allogeneic mesenchymal progenitor cells for posterolateral lumbar spine fusion in sheep.

Wheeler DL, Lane JM, Seim HB 3rd, Puttlitz CM, Itescu S, Turner AS.

Spine J. 2014 Mar 1;14(3):435-44. doi: 10.1016/j.spinee.2013.09.048. Epub 2013 Oct 23.

PMID:
24438940
10.

Intracoronary infusion of allogeneic mesenchymal precursor cells directly after experimental acute myocardial infarction reduces infarct size, abrogates adverse remodeling, and improves cardiac function.

Houtgraaf JH, de Jong R, Kazemi K, de Groot D, van der Spoel TI, Arslan F, Hoefer I, Pasterkamp G, Itescu S, Zijlstra F, Geleijnse ML, Serruys PW, Duckers HJ.

Circ Res. 2013 Jul 5;113(2):153-66. doi: 10.1161/CIRCRESAHA.112.300730. Epub 2013 May 8.

PMID:
23658436
11.

Catheter-based endomyocardial delivery of mesenchymal precursor cells using 3D echo guidance improves cardiac function in a chronic myocardial injury ovine model.

Cheng Y, Yi G, Conditt GB, Sheehy A, Kolodgie FD, Tellez A, Polyakov I, Gu A, Aboodi MS, Wallace-Bradley D, Schuster M, Martens T, Itescu S, Kaluza GL, Basu S, Virmani R, Granada JF, Sherman W.

Cell Transplant. 2013;22(12):2299-309. doi: 10.3727/096368912X658016. Epub 2012 Oct 25.

PMID:
23107489
12.

Immunoselected STRO-3+ mesenchymal precursor cells and restoration of the extracellular matrix of degenerate intervertebral discs.

Ghosh P, Moore R, Vernon-Roberts B, Goldschlager T, Pascoe D, Zannettino A, Gronthos S, Itescu S.

J Neurosurg Spine. 2012 May;16(5):479-88. doi: 10.3171/2012.1.SPINE11852. Epub 2012 Mar 9.

PMID:
22404141
13.

Short- and long-term outcomes of intracoronary and endogenously mobilized bone marrow stem cells in the treatment of ST-segment elevation myocardial infarction: a meta-analysis of randomized control trials.

Zimmet H, Porapakkham P, Porapakkham P, Sata Y, Haas SJ, Itescu S, Forbes A, Krum H.

Eur J Heart Fail. 2012 Jan;14(1):91-105. doi: 10.1093/eurjhf/hfr148. Epub 2011 Nov 6.

14.

Downregulation of the CXC chemokine receptor 4/stromal cell-derived factor 1 pathway enhances myocardial neovascularization, cardiomyocyte survival, and functional recovery after myocardial infarction.

Bonaros N, Sondermeijer H, Wiedemann D, Schlechta B, Schachner T, Schuster M, Seki T, Martens TP, Itescu S, Kocher AA.

J Thorac Cardiovasc Surg. 2011 Sep;142(3):687-96, 696.e1-2. doi: 10.1016/j.jtcvs.2011.01.014. Epub 2011 Mar 8.

15.

A comparison of mesenchymal precursor cells and amnion epithelial cells for enhancing cervical interbody fusion in an ovine model.

Goldschlager T, Ghosh P, Zannettino A, Williamson M, Rosenfeld JV, Itescu S, Jenkin G.

Neurosurgery. 2011 Apr;68(4):1025-34; discussion 1034-5. doi: 10.1227/NEU.0b013e31820d5375.

PMID:
21242823
16.

The efficacy of allogeneic mesenchymal precursor cells for the repair of an ovine tibial segmental defect.

Field JR, McGee M, Stanley R, Ruthenbeck G, Papadimitrakis T, Zannettino A, Gronthos S, Itescu S.

Vet Comp Orthop Traumatol. 2011;24(2):113-21. doi: 10.3415/VCOT-10-03-0046. Epub 2011 Jan 11. Erratum in: Vet Comp Orthop Traumatol. 2011;24(3):256.

PMID:
21225086
17.

Cervical interbody fusion is enhanced by allogeneic mesenchymal precursor cells in an ovine model.

Goldschlager T, Rosenfeld JV, Ghosh P, Itescu S, Blecher C, McLean C, Jenkin G.

Spine (Phila Pa 1976). 2011 Apr 15;36(8):615-23. doi: 10.1097/BRS.0b013e3181dfcec9.

PMID:
21192297
18.

Therapeutic effects of human STRO-3-selected mesenchymal precursor cells and their soluble factors in experimental myocardial ischemia.

See F, Seki T, Psaltis PJ, Sondermeijer HP, Gronthos S, Zannettino AC, Govaert KM, Schuster MD, Kurlansky PA, Kelly DJ, Krum H, Itescu S.

J Cell Mol Med. 2011 Oct;15(10):2117-29. doi: 10.1111/j.1582-4934.2010.01241.x.

19.

Reparative effects of allogeneic mesenchymal precursor cells delivered transendocardially in experimental nonischemic cardiomyopathy.

Psaltis PJ, Carbone A, Nelson AJ, Lau DH, Jantzen T, Manavis J, Williams K, Itescu S, Sanders P, Gronthos S, Zannettino AC, Worthley SG.

JACC Cardiovasc Interv. 2010 Sep;3(9):974-83. doi: 10.1016/j.jcin.2010.05.016.

20.

Comparative assessment of the osteoconductive properties of different biomaterials in vivo seeded with human or ovine mesenchymal stem/stromal cells.

Zannettino AC, Paton S, Itescu S, Gronthos S.

Tissue Eng Part A. 2010 Dec;16(12):3579-87. doi: 10.1089/ten.TEA.2010.0153. Epub 2010 Aug 30.

PMID:
20666614
21.

Cervical motion preservation using mesenchymal progenitor cells and pentosan polysulfate, a novel chondrogenic agent: preliminary study in an ovine model.

Goldschlager T, Ghosh P, Zannettino A, Gronthos S, Rosenfeld JV, Itescu S, Jenkin G.

Neurosurg Focus. 2010 Jun;28(6):E4. doi: 10.3171/2010.3.FOCUS1050.

PMID:
20521963
22.

Recommendations for successful training on methods of delivery of biologics for cardiac regeneration: a report of the International Society for Cardiovascular Translational Research.

Dib N, Menasche P, Bartunek JJ, Zeiher AM, Terzic A, Chronos NA, Henry TD, Peters NS, Fernández-Avilés F, Yacoub M, Sanborn TA, Demaria A, Schatz RA, Taylor DA, Fuchs S, Itescu S, Miller LW, Dinsmore JH, Dangas GD, Popma JJ, Hall JL, Holmes DR Jr; International Society for Cardiovascular Translational Research.

JACC Cardiovasc Interv. 2010 Mar;3(3):265-75. doi: 10.1016/j.jcin.2009.12.013.

23.

Pentosan polysulfate promotes proliferation and chondrogenic differentiation of adult human bone marrow-derived mesenchymal precursor cells.

Ghosh P, Wu J, Shimmon S, Zannettino AC, Gronthos S, Itescu S.

Arthritis Res Ther. 2010;12(1):R28. doi: 10.1186/ar2935. Epub 2010 Feb 18.

24.

Enrichment for STRO-1 expression enhances the cardiovascular paracrine activity of human bone marrow-derived mesenchymal cell populations.

Psaltis PJ, Paton S, See F, Arthur A, Martin S, Itescu S, Worthley SG, Gronthos S, Zannettino AC.

J Cell Physiol. 2010 May;223(2):530-40. doi: 10.1002/jcp.22081.

PMID:
20162565
25.

Islet grafting and imaging in a bioengineered intramuscular space.

Witkowski P, Sondermeijer H, Hardy MA, Woodland DC, Lee K, Bhagat G, Witkowski K, See F, Rana A, Maffei A, Itescu S, Harris PE.

Transplantation. 2009 Nov 15;88(9):1065-74. doi: 10.1097/TP.0b013e3181ba2e87.

26.

Mesenchymal cell transplantation and myocardial remodeling after myocardial infarction.

Dixon JA, Gorman RC, Stroud RE, Bouges S, Hirotsugu H, Gorman JH 3rd, Martens TP, Itescu S, Schuster MD, Plappert T, St John-Sutton MG, Spinale FG.

Circulation. 2009 Sep 15;120(11 Suppl):S220-9. doi: 10.1161/CIRCULATIONAHA.108.842302.

27.

Alloantibodies in heart transplantation.

Ho EK, Vlad G, Colovai AI, Vasilescu ER, Schwartz J, Sondermeijer H, Burke E, Marboe CC, Itescu S, Suciu-Foca N, Mancini D.

Hum Immunol. 2009 Oct;70(10):825-9. doi: 10.1016/j.humimm.2009.06.015. Epub 2009 Jun 23.

PMID:
19555730
28.

Heat shock protein-90 beta is expressed at the surface of multipotential mesenchymal precursor cells: generation of a novel monoclonal antibody, STRO-4, with specificity for mesenchymal precursor cells from human and ovine tissues.

Gronthos S, McCarty R, Mrozik K, Fitter S, Paton S, Menicanin D, Itescu S, Bartold PM, Xian C, Zannettino AC.

Stem Cells Dev. 2009 Nov;18(9):1253-62. doi: 10.1089/scd.2008.0400.

PMID:
19327008
29.

Allogeneic mesenchymal precursor cell therapy to limit remodeling after myocardial infarction: the effect of cell dosage.

Hamamoto H, Gorman JH 3rd, Ryan LP, Hinmon R, Martens TP, Schuster MD, Plappert T, Kiupel M, St John-Sutton MG, Itescu S, Gorman RC.

Ann Thorac Surg. 2009 Mar;87(3):794-801. doi: 10.1016/j.athoracsur.2008.11.057.

30.

Safety and efficacy of consecutive cycles of granulocyte-colony stimulating factor, and an intracoronary CD133+ cell infusion in patients with chronic refractory ischemic heart disease: the G-CSF in angina patients with IHD to stimulate neovascularization (GAIN I) trial.

Kovacic JC, Macdonald P, Feneley MP, Muller DW, Freund J, Dodds A, Milliken S, Tao H, Itescu S, Moore J, Ma D, Graham RM.

Am Heart J. 2008 Nov;156(5):954-63. doi: 10.1016/j.ahj.2008.04.034.

PMID:
19061712
31.

CCR3- and CXCR4-mediated interactions regulate migration of CD34+ human bone marrow progenitors to ischemic myocardium and subsequent tissue repair.

Bonaros N, Sondermeijer H, Schuster M, Rauf R, Wang SF, Seki T, Skerrett D, Itescu S, Kocher AA.

J Thorac Cardiovasc Surg. 2008 Oct;136(4):1044-53. doi: 10.1016/j.jtcvs.2007.12.067. Epub 2008 Jul 7. Erratum in: J Thorac Cardiovasc Surg. 2010 Apr 1;139(4):1089. Sondermejer, H [corrected to Sondermeijer, H].

32.

A novel monoclonal antibody (STRO-3) identifies an isoform of tissue nonspecific alkaline phosphatase expressed by multipotent bone marrow stromal stem cells.

Gronthos S, Fitter S, Diamond P, Simmons PJ, Itescu S, Zannettino AC.

Stem Cells Dev. 2007 Dec;16(6):953-63.

PMID:
18158854
33.

A DNA enzyme against plasminogen activator inhibitor- type 1 (PAI-1) limits neointima formation after angioplasty in an obese diabetic rodent model.

Witkowski P, Seki T, Xiang G, Martens T, Sondermeijer H, See F, Bhagat G, Schuster M, Hardy MA, Itescu S.

J Cardiovasc Pharmacol. 2007 Dec;50(6):633-40.

PMID:
18091579
34.
35.

Engineered cardiac tissues for in vitro assessment of contractile function and repair mechanisms.

Kim DE, Lee EJ, Martens TP, Kara R, Chaudhry HW, Itescu S, Costa KD.

Conf Proc IEEE Eng Med Biol Soc. 2006;1:849-52.

PMID:
17946863
36.

The changing pattern of humoral rejection in cardiac transplant recipients.

Almuti K, Haythe J, Dwyer E, Itescu S, Burke E, Green P, Marboe C, Mancini D.

Transplantation. 2007 Aug 27;84(4):498-503.

PMID:
17713434
37.

Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo.

Zannettino AC, Paton S, Arthur A, Khor F, Itescu S, Gimble JM, Gronthos S.

J Cell Physiol. 2008 Feb;214(2):413-21.

PMID:
17654479
38.

Anti-CD25 treatment and FOXP3-positive regulatory T cells in heart transplantation.

Vlad G, Ho EK, Vasilescu ER, Fan J, Liu Z, Cai JW, Jin Z, Burke E, Deng M, Cadeiras M, Cortesini R, Itescu S, Marboe C, Mancini D, Suciu-Foca N.

Transpl Immunol. 2007 Jul;18(1):13-21. Epub 2007 Apr 2.

PMID:
17584597
39.

Cardiac tissue engineering in an in vivo vascularized chamber.

Morritt AN, Bortolotto SK, Dilley RJ, Han X, Kompa AR, McCombe D, Wright CE, Itescu S, Angus JA, Morrison WA.

Circulation. 2007 Jan 23;115(3):353-60. Epub 2007 Jan 2.

PMID:
17200440
40.

Intravenous infusions of Albuminex 4% (human albumin 4%) and hypotension.

Itescu S, Hetzel R.

Crit Care Resusc. 2001 Mar;3(1):59. No abstract available.

PMID:
16597273
41.

Mesenchymal lineage precursor cells induce vascular network formation in ischemic myocardium.

Martens TP, See F, Schuster MD, Sondermeijer HP, Hefti MM, Zannettino A, Gronthos S, Seki T, Itescu S.

Nat Clin Pract Cardiovasc Med. 2006 Mar;3 Suppl 1:S18-22.

PMID:
16501624
42.

Acute antibody-mediated rejection of cardiac transplants.

Reed EF, Demetris AJ, Hammond E, Itescu S, Kobashigawa JA, Reinsmoen NL, Rodriguez ER, Rose M, Stewart S, Suciu-Foca N, Zeevi A, Fishbein MC; International Society for Heart and Lung Transplantation.

J Heart Lung Transplant. 2006 Feb;25(2):153-9. Review.

PMID:
16446213
43.

Myocardial homing and neovascularization by human bone marrow angioblasts is regulated by IL-8/Gro CXC chemokines.

Kocher AA, Schuster MD, Bonaros N, Lietz K, Xiang G, Martens TP, Kurlansky PA, Sondermeijer H, Witkowski P, Boyle A, Homma S, Wang SF, Itescu S.

J Mol Cell Cardiol. 2006 Apr;40(4):455-64. Epub 2006 Jan 24.

PMID:
16438981
44.

Cells expressing the stem cell factor receptor, c-kit, contribute to neoangiogenesis in diabetes.

Kelly DJ, Zhang Y, Gow RM, Itescu S, Gilbert RE.

Diab Vasc Dis Res. 2005 May;2(2):76-80.

PMID:
16305063
45.

Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection.

Stewart S, Winters GL, Fishbein MC, Tazelaar HD, Kobashigawa J, Abrams J, Andersen CB, Angelini A, Berry GJ, Burke MM, Demetris AJ, Hammond E, Itescu S, Marboe CC, McManus B, Reed EF, Reinsmoen NL, Rodriguez ER, Rose AG, Rose M, Suciu-Focia N, Zeevi A, Billingham ME.

J Heart Lung Transplant. 2005 Nov;24(11):1710-20. Epub 2005 Jun 20.

PMID:
16297770
46.
47.

Catalytic degradation of vitamin D up-regulated protein 1 mRNA enhances cardiomyocyte survival and prevents left ventricular remodeling after myocardial ischemia.

Xiang G, Seki T, Schuster MD, Witkowski P, Boyle AJ, See F, Martens TP, Kocher A, Sondermeijer H, Krum H, Itescu S.

J Biol Chem. 2005 Nov 25;280(47):39394-402. Epub 2005 Sep 19.

48.

Utility of post-transplant anti-HLA antibody measurements in pediatric cardiac transplant recipients.

Xydas S, Yang JK, Burke EM, Chen JM, Addonizio LJ, Mital SR, Itescu S, Hsu DT, Lamour JM.

J Heart Lung Transplant. 2005 Sep;24(9):1289-96.

PMID:
16143247
49.

Additive effects of endothelial progenitor cells combined with ACE inhibition and beta-blockade on left ventricular function following acute myocardial infarction.

Boyle AJ, Schuster M, Witkowski P, Xiang G, Seki T, Way K, Itescu S.

J Renin Angiotensin Aldosterone Syst. 2005 Mar;6(1):33-7.

PMID:
16088849
50.

Supplemental Content

Loading ...
Support Center